FLUORESCENCE POINT OF CARE IMAGING IMPROVES WOUND HEALING
posted: Nov. 27, 2020.
MolecuLight Inc., a leader in point-of-care fluorescence imaging for real-time detection of wounds containing bacteria, announced the publication of results in Diagnostics from a 2-year retrospective study of 229 foot ulcers. Diabetic foot ulcers represent a large and ever-increasing financial burden on the National Health Service (NHS), costing up to £962 million annually.
![]() |
Nadine Price |
"Diabetic foot ulcers (DFUs) and their bacterial burden produce a significant strain on the NHS (National Healthcare System) and I wanted to understand and quantify the effects of point-of-care fluorescence bacterial imaging on the costs and patient healing rates since the MolecuLight i:X was implemented at our clinic," says Nadine Price, study author and podiatrist at the Whipps Cross Hospital. "Beyond the significant realized cost savings that the study uncovered, the fluorescence imaging procedure has had a noticeable impact on the quality of wound care provided to patients, without detriment to our clinical workflow," says Price.
Source: Streetinsider.com [11/25/20]
Courtesy of Barry Block, editor of PM News